ILLUMIRA
Live / Applied — Ex parte appeal pending (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 31 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98578524
- Mark type
- Stylized text
- Filed
- 31 May 2024
- Attorney of record
- APRIL L. BESL
Goods and services
- Class 005 — Pharmaceuticals: Active pharmaceutical ingredients, namely, isotopes and radioisotopes for medical, therapeutic and theranostic use; active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and theranostic use; active pharmaceutical ingredients, namely non-carrier added lutetium 177; active pharmaceutical ingredients, namely, a radioisotope for the treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases
Owner
- Shine Technologies, LLC, Janesville, WI, US
Prosecution history
- 13 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Mar 2026 — ASSIGNED TO LIE
- 06 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 Mar 2026 — EX PARTE APPEAL-INSTITUTED
- 06 Mar 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 06 Mar 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 13 Feb 2026 — LETTER OF PROTEST EVIDENCE FORWARDED
- 04 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 04 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Sept 2025 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 26 Sept 2025 — SUBSEQUENT FINAL EMAILED
- 26 Sept 2025 — SUBSEQUENT FINAL REFUSAL WRITTEN
- 07 Aug 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 07 Aug 2025 — FINAL REFUSAL E-MAILED